 |
|
|
| |
CANCER INCIDENCE AMONG PERSONS ON MODERN SUPPRESSIVE ANTIRETROVIRAL THERAPY, 2000-12
|
| |
| |
"The median age at cancer diagnosis (Q1, Q3) was 48 years (41, 55) among HIV-positive and 68 years (58, 77) among HIV-negative cases. Specific cancers diagnosed among people with HIV are shown in Figure 1. The five most common cancers were non-Hodgkin lymphoma, Kaposi’s sarcoma, lung, anal and liver cancers, which altogether accounted for 75% of the 195 cases. Combining all cancers across all years, there was 58% excess cancer among people with HIV (age-adjusted incidence rate ratio, aIRR = 2.4 [2.0, 2.9]). This was higher among males at 74% (aIRR = 3.9 [3.2, 4.7]) compared to 38% among females (aIRR=1.6 [0.26, 2.9])."
Reported by Jules Levin
CROI 2017 Feb 14-16 Seattle, WA
Ann N. Burchell1,2, Kate Salters3, Oghenowede Eyawo4, Joanne Lindsay1, Jason Chia4, Michelle Cotterchio5, Mark Hull4, Monica Ye4, Janet Raboud6, Robert S. Hogg3,4 1. St. Michael’s Hospital, Toronto. 2. University of Toronto. 3. Simon Fraser University, Vancouver. 4. British Columbia Centre for Excellence in HIV/AIDS, Vancouver. 5. Cancer Care Ontario, Toronto. 6. Toronto General Research Institute, University Health Network, Toronto. CANADA
from Jules: and nadir CD4, current CD4, time with low CD4, viral load, time spent with detectable viral load; lifestyle: smoking, exercise, diet.
|
| |
|
|
|
|
|
